FDA Orange Book
Generic for Tamiflu
Tamiflu contains oseltamivir. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Tamiflu is oseltamivir. 23 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 4 of the 5 Tamiflu products the Orange Book lists.
Run it in Rivvi
Map Tamiflu and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Tamiflu products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, oral | EQ 30MG BASE | Discontinued | None | 16 | AB |
| capsule, oral | EQ 45MG BASE | Discontinued | None | 15 | AB |
| capsule, oral | EQ 75MG BASE | Marketed (Rx) | AB | 16 | AB |
| for suspension, oral | EQ 12MG BASE/ML | Discontinued | None | 0 | None |
| for suspension, oral | EQ 6MG BASE/ML | Marketed (Rx) | AB | 15 | AB |
NDA 021087, 021246, held by HOFFMANN LA ROCHE INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic oseltamivir
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| NATCO PHARMA LTD | 202595 | AB (A-rated, therapeutically equivalent) | August 3, 2016 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| ZYDUS PHARMACEUTICALS USA INC | 208578 | AB (A-rated, therapeutically equivalent) | February 24, 2017 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| AMNEAL PHARMACEUTICALS OF NEW YORK LLC | 209093 | AB (A-rated, therapeutically equivalent) | May 17, 2017 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| MACLEODS PHARMACEUTICALS LTD | 207211 | AB (A-rated, therapeutically equivalent) | September 14, 2017 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| ZYDUS PHARMACEUTICALS USA INC | 209113 | AB (A-rated, therapeutically equivalent) | September 14, 2017 | EQ 6MG BASE/ML |
| ALVOGEN INC | 208823 | AB (A-rated, therapeutically equivalent) | October 31, 2017 | EQ 6MG BASE/ML |
| LUPIN INC | 208348 | AB (A-rated, therapeutically equivalent) | January 9, 2018 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| LUPIN INC | 208347 | AB (A-rated, therapeutically equivalent) | February 20, 2018 | EQ 6MG BASE/ML |
| HETERO LABS LTD UNIT III | 209438 | AB (A-rated, therapeutically equivalent) | February 23, 2018 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| STRIDES PHARMA GLOBAL PTE LTD | 209421 | AB (A-rated, therapeutically equivalent) | June 8, 2018 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| TEVA PHARMACEUTICALS USA INC | 211125 | AB (A-rated, therapeutically equivalent) | February 27, 2019 | EQ 6MG BASE/ML |
| ALEMBIC PHARMACEUTICALS LTD | 211823 | AB (A-rated, therapeutically equivalent) | June 24, 2019 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| SUNSHINE LAKE PHARMA CO LTD | 212739 | AB (A-rated, therapeutically equivalent) | March 4, 2020 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| MSN LABORATORIES PRIVATE LTD | 212544 | AB (A-rated, therapeutically equivalent) | May 20, 2020 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| AJANTA PHARMA LTD | 212784 | AB (A-rated, therapeutically equivalent) | May 27, 2020 | EQ 6MG BASE/ML |
| INVAGEN PHARMACEUTICALS INC | 212858 | AB (A-rated, therapeutically equivalent) | August 30, 2021 | EQ 6MG BASE/ML |
| EPIC PHARMA LLC | 215208 | AB (A-rated, therapeutically equivalent) | October 1, 2021 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| SUNSHINE LAKE PHARMA CO LTD | 213594 | AB (A-rated, therapeutically equivalent) | January 5, 2022 | EQ 6MG BASE/ML |
| STRIDES PHARMA GLOBAL PTE LTD | 211894 | AB (A-rated, therapeutically equivalent) | January 13, 2022 | EQ 6MG BASE/ML |
| HETERO LABS LTD UNIT V | 209590 | AB (A-rated, therapeutically equivalent) | March 28, 2022 | EQ 6MG BASE/ML |
| MSN LABORATORIES PRIVATE LTD | 215313 | AB (A-rated, therapeutically equivalent) | May 2, 2022 | EQ 6MG BASE/ML |
| EPIC PHARMA LLC | 215538 | AB (A-rated, therapeutically equivalent) | February 14, 2023 | EQ 6MG BASE/ML |
| INVAGEN PHARMACEUTICALS INC | 217467 | AB (A-rated, therapeutically equivalent) | October 3, 2023 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| LAURUS LABS LTD | 218565 | AB (A-rated, therapeutically equivalent) | May 1, 2024 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| AUROBINDO PHARMA LTD | 218131 | AB (A-rated, therapeutically equivalent) | May 10, 2024 | EQ 6MG BASE/ML |
| PHARMOBEDIENT CONSULTING LLC | 217303 | AB (A-rated, therapeutically equivalent) | July 2, 2024 | EQ 6MG BASE/ML |
| BEIJING JIALIN PHARMACEUTICAL CO LTD | 217133 | AB (A-rated, therapeutically equivalent) | October 30, 2024 | EQ 30MG BASE, EQ 75MG BASE |
| JUBILANT GENERICS LTD | 213695 | AB (A-rated, therapeutically equivalent) | March 3, 2025 | EQ 6MG BASE/ML |
| SHANDONG NEW TIME PHARMACEUTICAL CO LTD | 217274 | AB (A-rated, therapeutically equivalent) | July 9, 2025 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| ZHEJIANG POLY PHARM CO LTD | 218009 | AB (A-rated, therapeutically equivalent) | October 2, 2025 | EQ 30MG BASE, EQ 45MG BASE, EQ 75MG BASE |
| ALEMBIC PHARMACEUTICALS LTD | 218307 | AB (A-rated, therapeutically equivalent) | June 25, 2026 | EQ 6MG BASE/ML |
Tamiflu NDC codes
Questions
Is there a generic for Tamiflu?
Yes. The generic name for Tamiflu is oseltamivir. 23 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 4 of the 5 Tamiflu products the Orange Book lists.
What is the generic name for Tamiflu?
The active ingredient in Tamiflu is oseltamivir, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.